CRISPR Archives

maurizio montalti bioart synthetic bio biotech

News and Trends 2 Dec 2015

How Can BioArt Help Geneticists and the Biotech Field?

BioArt is a hot interdisciplinary sub-genre springing up in Galleries all over Europe. Here is a summary of a review on the movements increasing relevance to the Biotech Industry… In part thanks to the Biohacking and DIY Biotech movement, accessibility to lab equipment, 3D-printers, and the popularity of the Synthetic Biology iGEM Competition, artists around […]

December 2, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 2 Nov 2015

The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too

So, we all know the CRISPR Success story with Emmanuelle Charpentier & Jennifer Doudna, who have received multiple awards and constant celebration of their pioneering work in 2012. However, what about the guy who really first described the CRISPR-Cas9 mechanism all the way back in 2007? Finally, he gets some recognition too. Senior DuPont scientist […]

November 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 31 Oct 2015

What Happened this Week? An Incredible Woman, CRISPR deal, CAR-T milestone

Monday: Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal Tuesday: Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease Wednesday: Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome Thursday: Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer Friday: Purple GMO Tomatoes […]

October 31, 2015 - 1 minutemin - By Philip Hemme

News and Trends 10 Oct 2015

What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research

Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history Tuesday: An Insider’s experience at the iGEM Giant Boston Jamboree 2015 Wednesday: Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize! Thursday: The Future Biotech Lab Bench: My experience of the cutting edge-tech at LABVOLUTION Friday: Alzheimer’s Disease: Phase III breakthrough Tau-therapy earns […]

October 10, 2015 - 1 minutemin - By Philip Hemme

News and Trends 7 Oct 2015

Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!

The first paper on CRISPR gene editing tech was only published in 2012. As a key player in the biotech revolution, CRISPR is the discovery of the century, permitting a whole new field of gene-editing for therapeutic purposes in a range of different research areas. Two of those responsible for the existence of CRISPR-Cas9, Jennifer […]

October 7, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 3 Oct 2015

What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

Monday: AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping) Tuesday: Will Roche lose it’s Worldwide Leading position in Cancer treatments? Wednesday: CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9? Thursday: Artificially Intelligent ‘Betsy’ will analyse 100,000 genomes for UK Government Friday: Merck relinquishes Rare Disease license to instead […]

October 3, 2015 - 1 minutemin - By Philip Hemme

News and Trends 30 Sep 2015

CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?

CRISPR is already revolutionizing Biotechnology. However, like every biotech revolution, there then follows a patent war. But the discovery of a new gene editing protein (Cpf1), with the potential of replacing Cas9, could change this status-quo. As Business Insider puts its, CRISPR is “the biggest biotech discovery of the century“. And its true, it really changed […]

September 30, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 22 Sep 2015

Francis Crick Institute pushes to do human embryo research

The Francis Crick Institute from London has announced its application to conduct non-clinical purpose research on human embryos. The Francis Crick Institute is a cutting-edge collaboration of the UK’s leading medical research organisations: the Medical Research Council, Cancer Research UK, various London academic institutions and the Wellcome Trust. Currently still under construction, it is based in […]

September 22, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 17 Sep 2015

Welcome to the Golden age for Gene Editing!

Nuclease-based gene editing technology has opened up how biotechs approach genomic research in industry. A review by Boston Consulting Group explores the background to this excitingly complex field, highlighting how the lengthy genetic revolution has been leading up to this point. Boston Consulting Group has released a report on the importance of gene editing to […]

September 17, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 16 Aug 2015

What happened this week? Woodford spent €800m, CRISPR discoverer moves to Berlin, the first Bacteria-made ink…

Encouraging facts for the European Biotech ecosystem this week! Neil Woodford’s mega Biotech fund is gathering new money to pour over the European companies. Definitely good news for the financing of companies in Europe, which still lags behind the US. Another interesting fact is that one of the co-discoverer of CRISPRs, the biggest discovery of the century, […]

August 16, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 13 Aug 2015

Emmanuelle Charpentier, co-discoverer of CRISPR-Cas9 Technology, comes to Berlin!

French, young and brilliant, Emmanuelle Charpentier will now be working as a director at the Max Planck Institute for Infection Biology in Berlin! Emmanuelle Charpentier is labeled one of the most influential scientists by the Time magazine when she discovered THE new technology of the century: CRISPR-Cas9. Among numerous honors, she won the $3M Breakthrough Prizes […]

August 13, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 12 Aug 2015

CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey

A new strategic movement in the hot CRISPR field: CRISPR Therapeutics ramps up its leadership team with Samarth Kulkarni as its new Chief Business Officer and Michael Bruce as Senior Vice President to moderate program portfolio and alliance management. In the meantime, CRISPR’s main competitor EditasMedicine procured €108M to accelerate its CRISPR-based therapies in clinical state. […]

August 12, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

CRISPR

How Can BioArt Help Geneticists and the Biotech Field?

The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too

What Happened this Week? An Incredible Woman, CRISPR deal, CAR-T milestone

What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research

Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!

What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?

Francis Crick Institute pushes to do human embryo research

Welcome to the Golden age for Gene Editing!

What happened this week? Woodford spent €800m, CRISPR discoverer moves to Berlin, the first Bacteria-made ink…

Emmanuelle Charpentier, co-discoverer of CRISPR-Cas9 Technology, comes to Berlin!

CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!